Biomarker ID | 450 |
PMID | 19505924 |
Year | 2009 |
Biomarker | Prostatic Acid Phosphatase (PAP) |
Biomarker Basis | Expression Based |
Biomolecule | Metabolites |
Source | Blood |
Subjects | Humans |
Regulation | Increased expression in overall survival |
Odds Ratio/Hazard Ratio/Relative Risk | Univariate: HR: 3.39 95% CI: (2.09-5.51) |
Effect on Pathways | NA |
Experiment | Overall Survival Vs No Survival |
Type of Biomarker | Prognostic |
Cohort | 100 patients with prostate cancer were selected to determine the overall survival for checkup after 26 months. 49 were dead after the study and 51 were alive. |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | p<0.001 |
Method Used | Assays |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | ACP3 |